LV and MV Switchgear
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Colloids (Blood Plasma) Market Outlook 2024
1 Colloids (Blood Plasma) Market Overview
1.1 Product Overview and Scope of Colloids (Blood Plasma)
1.2 Colloids (Blood Plasma) Segment by Type
1.2.1 Global Colloids (Blood Plasma) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Natural Type Colloids (Blood Plasma)
1.2.3 Synthetic Type Colloids (Blood Plasma)
1.3 Colloids (Blood Plasma) Segment by Application
1.3.1 Global Colloids (Blood Plasma) Sales Comparison by Application: (2021-2027)
1.3.2 Extensive Burns
1.3.3 Massive Blood or Plasma Loss
1.3.4 Hypovolemic Shock
1.3.5 Others
1.4 Global Colloids (Blood Plasma) Market Size Estimates and Forecasts
1.4.1 Global Colloids (Blood Plasma) Revenue 2016-2027
1.4.2 Global Colloids (Blood Plasma) Sales 2016-2027
1.4.3 Colloids (Blood Plasma) Market Size by Region: 2016 Versus 2021 Versus 2027
2 Colloids (Blood Plasma) Market Competition by Manufacturers
2.1 Global Colloids (Blood Plasma) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Colloids (Blood Plasma) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Colloids (Blood Plasma) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Colloids (Blood Plasma) Manufacturing Sites, Area Served, Product Type
2.5 Colloids (Blood Plasma) Market Competitive Situation and Trends
2.5.1 Colloids (Blood Plasma) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Colloids (Blood Plasma) Players Market Share by Revenue
2.5.3 Global Colloids (Blood Plasma) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Colloids (Blood Plasma) Retrospective Market Scenario by Region
3.1 Global Colloids (Blood Plasma) Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Colloids (Blood Plasma) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Colloids (Blood Plasma) Market Facts & Figures by Country
3.3.1 North America Colloids (Blood Plasma) Sales by Country
3.3.2 North America Colloids (Blood Plasma) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Colloids (Blood Plasma) Market Facts & Figures by Country
3.4.1 Europe Colloids (Blood Plasma) Sales by Country
3.4.2 Europe Colloids (Blood Plasma) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Colloids (Blood Plasma) Market Facts & Figures by Region
3.5.1 Asia Pacific Colloids (Blood Plasma) Sales by Region
3.5.2 Asia Pacific Colloids (Blood Plasma) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Colloids (Blood Plasma) Market Facts & Figures by Country
3.6.1 Latin America Colloids (Blood Plasma) Sales by Country
3.6.2 Latin America Colloids (Blood Plasma) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Colloids (Blood Plasma) Market Facts & Figures by Country
3.7.1 Middle East and Africa Colloids (Blood Plasma) Sales by Country
3.7.2 Middle East and Africa Colloids (Blood Plasma) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Colloids (Blood Plasma) Historic Market Analysis by Type
4.1 Global Colloids (Blood Plasma) Sales Market Share by Type (2016-2021)
4.2 Global Colloids (Blood Plasma) Revenue Market Share by Type (2016-2021)
4.3 Global Colloids (Blood Plasma) Price by Type (2016-2021)
5 Global Colloids (Blood Plasma) Historic Market Analysis by Application
5.1 Global Colloids (Blood Plasma) Sales Market Share by Application (2016-2021)
5.2 Global Colloids (Blood Plasma) Revenue Market Share by Application (2016-2021)
5.3 Global Colloids (Blood Plasma) Price by Application (2016-2021)
6 Key Companies Profiled
6.1 CSL Behring
6.1.1 CSL Behring Corporation Information
6.1.2 CSL Behring Description and Business Overview
6.1.3 CSL Behring Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 CSL Behring Colloids (Blood Plasma) Product Portfolio
6.1.5 CSL Behring Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Corporation Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Baxter Colloids (Blood Plasma) Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Corporation Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Grifols Colloids (Blood Plasma) Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 Octapharma
6.4.1 Octapharma Corporation Information
6.4.2 Octapharma Description and Business Overview
6.4.3 Octapharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Octapharma Colloids (Blood Plasma) Product Portfolio
6.4.5 Octapharma Recent Developments/Updates
6.5 Kedrion
6.5.1 Kedrion Corporation Information
6.5.2 Kedrion Description and Business Overview
6.5.3 Kedrion Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Kedrion Colloids (Blood Plasma) Product Portfolio
6.5.5 Kedrion Recent Developments/Updates
6.6 Shanghai Raas
6.6.1 Shanghai Raas Corporation Information
6.6.2 Shanghai Raas Description and Business Overview
6.6.3 Shanghai Raas Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Shanghai Raas Colloids (Blood Plasma) Product Portfolio
6.6.5 Shanghai Raas Recent Developments/Updates
6.7 CTBB
6.6.1 CTBB Corporation Information
6.6.2 CTBB Description and Business Overview
6.6.3 CTBB Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 CTBB Colloids (Blood Plasma) Product Portfolio
6.7.5 CTBB Recent Developments/Updates
6.8 Hualan Bio
6.8.1 Hualan Bio Corporation Information
6.8.2 Hualan Bio Description and Business Overview
6.8.3 Hualan Bio Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Hualan Bio Colloids (Blood Plasma) Product Portfolio
6.8.5 Hualan Bio Recent Developments/Updates
6.9 Rongsheng Pharmaceutical
6.9.1 Rongsheng Pharmaceutical Corporation Information
6.9.2 Rongsheng Pharmaceutical Description and Business Overview
6.9.3 Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Rongsheng Pharmaceutical Colloids (Blood Plasma) Product Portfolio
6.9.5 Rongsheng Pharmaceutical Recent Developments/Updates
6.10 Boya Rongsheng
6.10.1 Boya Rongsheng Corporation Information
6.10.2 Boya Rongsheng Description and Business Overview
6.10.3 Boya Rongsheng Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Boya Rongsheng Colloids (Blood Plasma) Product Portfolio
6.10.5 Boya Rongsheng Recent Developments/Updates
6.11 B. Braun Medical
6.11.1 B. Braun Medical Corporation Information
6.11.2 B. Braun Medical Colloids (Blood Plasma) Description and Business Overview
6.11.3 B. Braun Medical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
6.11.4 B. Braun Medical Colloids (Blood Plasma) Product Portfolio
6.11.5 B. Braun Medical Recent Developments/Updates
6.12 Fresenius Kabi
6.12.1 Fresenius Kabi Corporation Information
6.12.2 Fresenius Kabi Colloids (Blood Plasma) Description and Business Overview
6.12.3 Fresenius Kabi Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Fresenius Kabi Colloids (Blood Plasma) Product Portfolio
6.12.5 Fresenius Kabi Recent Developments/Updates
6.13 HOSPIRA
6.13.1 HOSPIRA Corporation Information
6.13.2 HOSPIRA Colloids (Blood Plasma) Description and Business Overview
6.13.3 HOSPIRA Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
6.13.4 HOSPIRA Colloids (Blood Plasma) Product Portfolio
6.13.5 HOSPIRA Recent Developments/Updates
6.14 Axa parenterals
6.14.1 Axa parenterals Corporation Information
6.14.2 Axa parenterals Colloids (Blood Plasma) Description and Business Overview
6.14.3 Axa parenterals Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Axa parenterals Colloids (Blood Plasma) Product Portfolio
6.14.5 Axa parenterals Recent Developments/Updates
6.15 Fresenius Kabi(China)
6.15.1 Fresenius Kabi(China) Corporation Information
6.15.2 Fresenius Kabi(China) Colloids (Blood Plasma) Description and Business Overview
6.15.3 Fresenius Kabi(China) Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Fresenius Kabi(China) Colloids (Blood Plasma) Product Portfolio
6.15.5 Fresenius Kabi(China) Recent Developments/Updates
6.16 CR Double-Crane
6.16.1 CR Double-Crane Corporation Information
6.16.2 CR Double-Crane Colloids (Blood Plasma) Description and Business Overview
6.16.3 CR Double-Crane Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
6.16.4 CR Double-Crane Colloids (Blood Plasma) Product Portfolio
6.16.5 CR Double-Crane Recent Developments/Updates
6.17 Kelun Group
6.17.1 Kelun Group Corporation Information
6.17.2 Kelun Group Colloids (Blood Plasma) Description and Business Overview
6.17.3 Kelun Group Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Kelun Group Colloids (Blood Plasma) Product Portfolio
6.17.5 Kelun Group Recent Developments/Updates
6.18 Shandong Qidu Pharmaceutical
6.18.1 Shandong Qidu Pharmaceutical Corporation Information
6.18.2 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Description and Business Overview
6.18.3 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
6.18.5 Shandong Qidu Pharmaceutical Recent Developments/Updates
6.19 Shandong Hualu Pharmaceutical
6.19.1 Shandong Hualu Pharmaceutical Corporation Information
6.19.2 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Description and Business Overview
6.19.3 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product Portfolio
6.19.5 Shandong Hualu Pharmaceutical Recent Developments/Updates
6.20 Minsheng Pharma
6.20.1 Minsheng Pharma Corporation Information
6.20.2 Minsheng Pharma Colloids (Blood Plasma) Description and Business Overview
6.20.3 Minsheng Pharma Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Minsheng Pharma Colloids (Blood Plasma) Product Portfolio
6.20.5 Minsheng Pharma Recent Developments/Updates
6.21 Kanglepharm
6.21.1 Kanglepharm Corporation Information
6.21.2 Kanglepharm Colloids (Blood Plasma) Description and Business Overview
6.21.3 Kanglepharm Colloids (Blood Plasma) Sales, Revenue and Gross Margin (2016-2021)
6.21.4 Kanglepharm Colloids (Blood Plasma) Product Portfolio
6.21.5 Kanglepharm Recent Developments/Updates
7 Colloids (Blood Plasma) Manufacturing Cost Analysis
7.1 Colloids (Blood Plasma) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Colloids (Blood Plasma)
7.4 Colloids (Blood Plasma) Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Colloids (Blood Plasma) Distributors List
8.3 Colloids (Blood Plasma) Customers
9 Colloids (Blood Plasma) Market Dynamics
9.1 Colloids (Blood Plasma) Industry Trends
9.2 Colloids (Blood Plasma) Growth Drivers
9.3 Colloids (Blood Plasma) Market Challenges
9.4 Colloids (Blood Plasma) Market Restraints
10 Global Market Forecast
10.1 Colloids (Blood Plasma) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Colloids (Blood Plasma) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Colloids (Blood Plasma) by Type (2022-2027)
10.2 Colloids (Blood Plasma) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Colloids (Blood Plasma) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Colloids (Blood Plasma) by Application (2022-2027)
10.3 Colloids (Blood Plasma) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Colloids (Blood Plasma) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Colloids (Blood Plasma) by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Colloids (Blood Plasma) Sales (MT) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Colloids (Blood Plasma) Sales (MT) Comparison by Application (2021-2027)
Table 3. Global Colloids (Blood Plasma) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Colloids (Blood Plasma) Covered in This Study
Table 5. Global Colloids (Blood Plasma) Sales (MT) of Key Manufacturers (2016-2021)
Table 6. Global Colloids (Blood Plasma) Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Colloids (Blood Plasma) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Colloids (Blood Plasma) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Colloids (Blood Plasma) Average Price (USD/Kg) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Colloids (Blood Plasma) Manufacturing Sites and Area Served
Table 11. Manufacturers Colloids (Blood Plasma) Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Colloids (Blood Plasma) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Colloids (Blood Plasma) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Colloids (Blood Plasma) Sales by Region (2016-2021) & (MT)
Table 16. Global Colloids (Blood Plasma) Sales Market Share by Region (2016-2021)
Table 17. Global Colloids (Blood Plasma) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Colloids (Blood Plasma) Sales by Country (2016-2021) & (MT)
Table 19. North America Colloids (Blood Plasma) Sales Market Share by Country (2016-2021)
Table 20. North America Colloids (Blood Plasma) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Colloids (Blood Plasma) Revenue Market Share by Country (2016-2021)
Table 22. Europe Colloids (Blood Plasma) Sales by Country (2016-2021) & (MT)
Table 23. Europe Colloids (Blood Plasma) Sales Market Share by Country (2016-2021)
Table 24. Europe Colloids (Blood Plasma) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Colloids (Blood Plasma) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Colloids (Blood Plasma) Sales by Region (2016-2021) & (MT)
Table 27. Asia Pacific Colloids (Blood Plasma) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Colloids (Blood Plasma) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Colloids (Blood Plasma) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Colloids (Blood Plasma) Sales by Country (2016-2021) & (MT)
Table 31. Latin America Colloids (Blood Plasma) Sales Market Share by Country (2016-2021)
Table 32. Latin America Colloids (Blood Plasma) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Colloids (Blood Plasma) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Colloids (Blood Plasma) Sales by Country (2016-2021) & (MT)
Table 35. Middle East and Africa Colloids (Blood Plasma) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Colloids (Blood Plasma) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Colloids (Blood Plasma) Revenue Market Share by Country (2016-2021)
Table 38. Global Colloids (Blood Plasma) Sales (MT) by Type (2016-2021)
Table 39. Global Colloids (Blood Plasma) Sales Market Share by Type (2016-2021)
Table 40. Global Colloids (Blood Plasma) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Colloids (Blood Plasma) Revenue Share by Type (2016-2021)
Table 42. Global Colloids (Blood Plasma) Price (USD/Kg) by Type (2016-2021)
Table 43. Global Colloids (Blood Plasma) Sales (MT) by Application (2016-2021)
Table 44. Global Colloids (Blood Plasma) Sales Market Share by Application (2016-2021)
Table 45. Global Colloids (Blood Plasma) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Colloids (Blood Plasma) Revenue Share by Application (2016-2021)
Table 47. Global Colloids (Blood Plasma) Price (USD/Kg) by Application (2016-2021)
Table 48. CSL Behring Corporation Information
Table 49. CSL Behring Description and Business Overview
Table 50. CSL Behring Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 51. CSL Behring Colloids (Blood Plasma) Product
Table 52. CSL Behring Recent Developments/Updates
Table 53. Baxter Corporation Information
Table 54. Baxter Description and Business Overview
Table 55. Baxter Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 56. Baxter Colloids (Blood Plasma) Product
Table 57. Baxter Recent Developments/Updates
Table 58. Grifols Corporation Information
Table 59. Grifols Description and Business Overview
Table 60. Grifols Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 61. Grifols Colloids (Blood Plasma) Product
Table 62. Grifols Recent Developments/Updates
Table 63. Octapharma Corporation Information
Table 64. Octapharma Description and Business Overview
Table 65. Octapharma Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 66. Octapharma Colloids (Blood Plasma) Product
Table 67. Octapharma Recent Developments/Updates
Table 68. Kedrion Corporation Information
Table 69. Kedrion Description and Business Overview
Table 70. Kedrion Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 71. Kedrion Colloids (Blood Plasma) Product
Table 72. Kedrion Recent Developments/Updates
Table 73. Shanghai Raas Corporation Information
Table 74. Shanghai Raas Description and Business Overview
Table 75. Shanghai Raas Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 76. Shanghai Raas Colloids (Blood Plasma) Product
Table 77. Shanghai Raas Recent Developments/Updates
Table 78. CTBB Corporation Information
Table 79. CTBB Description and Business Overview
Table 80. CTBB Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 81. CTBB Colloids (Blood Plasma) Product
Table 82. CTBB Recent Developments/Updates
Table 83. Hualan Bio Corporation Information
Table 84. Hualan Bio Description and Business Overview
Table 85. Hualan Bio Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 86. Hualan Bio Colloids (Blood Plasma) Product
Table 87. Hualan Bio Recent Developments/Updates
Table 88. Rongsheng Pharmaceutical Corporation Information
Table 89. Rongsheng Pharmaceutical Description and Business Overview
Table 90. Rongsheng Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 91. Rongsheng Pharmaceutical Colloids (Blood Plasma) Product
Table 92. Rongsheng Pharmaceutical Recent Developments/Updates
Table 93. Boya Rongsheng Corporation Information
Table 94. Boya Rongsheng Description and Business Overview
Table 95. Boya Rongsheng Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 96. Boya Rongsheng Colloids (Blood Plasma) Product
Table 97. Boya Rongsheng Recent Developments/Updates
Table 98. B. Braun Medical Corporation Information
Table 99. B. Braun Medical Description and Business Overview
Table 100. B. Braun Medical Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 101. B. Braun Medical Colloids (Blood Plasma) Product
Table 102. B. Braun Medical Recent Developments/Updates
Table 103. Fresenius Kabi Corporation Information
Table 104. Fresenius Kabi Description and Business Overview
Table 105. Fresenius Kabi Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 106. Fresenius Kabi Colloids (Blood Plasma) Product
Table 107. Fresenius Kabi Recent Developments/Updates
Table 108. HOSPIRA Corporation Information
Table 109. HOSPIRA Description and Business Overview
Table 110. HOSPIRA Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 111. HOSPIRA Colloids (Blood Plasma) Product
Table 112. HOSPIRA Recent Developments/Updates
Table 113. Axa parenterals Corporation Information
Table 114. Axa parenterals Description and Business Overview
Table 115. Axa parenterals Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 116. Axa parenterals Colloids (Blood Plasma) Product
Table 117. Axa parenterals Recent Developments/Updates
Table 118. Fresenius Kabi(China) Corporation Information
Table 119. Fresenius Kabi(China) Description and Business Overview
Table 120. Fresenius Kabi(China) Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 121. Fresenius Kabi(China) Colloids (Blood Plasma) Product
Table 122. Fresenius Kabi(China) Recent Developments/Updates
Table 123. CR Double-Crane Corporation Information
Table 124. CR Double-Crane Description and Business Overview
Table 125. CR Double-Crane Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 126. CR Double-Crane Colloids (Blood Plasma) Product
Table 127. CR Double-Crane Recent Developments/Updates
Table 128. Kelun Group Corporation Information
Table 129. Kelun Group Description and Business Overview
Table 130. Kelun Group Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 131. Kelun Group Colloids (Blood Plasma) Product
Table 132. Kelun Group Recent Developments/Updates
Table 133. Shandong Qidu Pharmaceutical Corporation Information
Table 134. Shandong Qidu Pharmaceutical Description and Business Overview
Table 135. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 136. Shandong Qidu Pharmaceutical Colloids (Blood Plasma) Product
Table 137. Shandong Qidu Pharmaceutical Recent Developments/Updates
Table 138. Shandong Hualu Pharmaceutical Corporation Information
Table 139. Shandong Hualu Pharmaceutical Description and Business Overview
Table 140. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 141. Shandong Hualu Pharmaceutical Colloids (Blood Plasma) Product
Table 142. Shandong Hualu Pharmaceutical Recent Developments/Updates
Table 143. Minsheng Pharma Corporation Information
Table 144. Minsheng Pharma Description and Business Overview
Table 145. Minsheng Pharma Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 146. Minsheng Pharma Colloids (Blood Plasma) Product
Table 147. Minsheng Pharma Recent Developments/Updates
Table 148. Kanglepharm Corporation Information
Table 149. Kanglepharm Description and Business Overview
Table 150. Kanglepharm Colloids (Blood Plasma) Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2021)
Table 151. Kanglepharm Colloids (Blood Plasma) Product
Table 152. Kanglepharm Recent Developments/Updates
Table 153. Production Base and Market Concentration Rate of Raw Material
Table 154. Key Suppliers of Raw Materials
Table 155. Colloids (Blood Plasma) Distributors List
Table 156. Colloids (Blood Plasma) Customers List
Table 157. Colloids (Blood Plasma) Market Trends
Table 158. Colloids (Blood Plasma) Growth Drivers
Table 159. Colloids (Blood Plasma) Market Challenges
Table 160. Colloids (Blood Plasma) Market Restraints
Table 161. Global Colloids (Blood Plasma) Sales Forecast by Type (2022-2027) & (MT)
Table 162. Global Colloids (Blood Plasma) Sales Market Share Forecast by Type (2022-2027)
Table 163. Global Colloids (Blood Plasma) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 164. Global Colloids (Blood Plasma) Revenue Market Share Forecast by Type (2022-2027)
Table 165. Global Colloids (Blood Plasma) Sales Forecast by Application (2022-2027) & (MT)
Table 166. Global Colloids (Blood Plasma) Sales Market Share Forecast by Application (2022-2027)
Table 167. Global Colloids (Blood Plasma) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 168. Global Colloids (Blood Plasma) Revenue Market Share Forecast by Application (2022-2027)
Table 169. Global Colloids (Blood Plasma) Sales Forecast by Region (2022-2027) & (MT)
Table 170. Global Colloids (Blood Plasma) Sales Market Share Forecast by Region (2022-2027)
Table 171. Global Colloids (Blood Plasma) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 172. Global Colloids (Blood Plasma) Revenue Market Share Forecast by Region (2022-2027)
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Colloids (Blood Plasma)
Figure 2. Global Colloids (Blood Plasma) Market Share by Type in 2020 & 2027
Figure 3. Natural Type Colloids (Blood Plasma) Product Picture
Figure 4. Synthetic Type Colloids (Blood Plasma) Product Picture
Figure 5. Global Colloids (Blood Plasma) Market Share by Application in 2020 & 2027
Figure 6. Extensive Burns
Figure 7. Massive Blood or Plasma Loss
Figure 8. Hypovolemic Shock
Figure 9. Others
Figure 10. Global Colloids (Blood Plasma) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Colloids (Blood Plasma) Market Size 2016-2027 (US$ Million)
Figure 12. Global Colloids (Blood Plasma) Sales 2016-2027 (MT)
Figure 13. Global Colloids (Blood Plasma) Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Colloids (Blood Plasma) Sales Share by Manufacturers in 2020
Figure 15. Global Colloids (Blood Plasma) Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Colloids (Blood Plasma) Players: Market Share by Revenue in 2020
Figure 17. Colloids (Blood Plasma) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Colloids (Blood Plasma) Sales Market Share by Region (2016-2021)
Figure 19. Global Colloids (Blood Plasma) Sales Market Share by Region in 2020
Figure 20. Global Colloids (Blood Plasma) Revenue Market Share by Region (2016-2021)
Figure 21. Global Colloids (Blood Plasma) Revenue Market Share by Region in 2020
Figure 22. U.S. Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. U.A.E Colloids (Blood Plasma) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Colloids (Blood Plasma) by Type (2016-2021)
Figure 47. Sales Market Share of Colloids (Blood Plasma) by Application (2016-2021)
Figure 48. Sales Market Share of Colloids (Blood Plasma) by Application in 2020
Figure 49. Revenue Share of Colloids (Blood Plasma) by Application (2016-2021)
Figure 50. Revenue Share of Colloids (Blood Plasma) by Application in 2020
Figure 51. Manufacturing Cost Structure of Colloids (Blood Plasma)
Figure 52. Manufacturing Process Analysis of Colloids (Blood Plasma)
Figure 53. Colloids (Blood Plasma) Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
CSL Behring Baxter Grifols Octapharma Kedrion Shanghai Raas CTBB Hualan Bio Rongsheng Pharmaceutical Boya Rongsheng B. Braun Medical Fresenius Kabi HOSPIRA Axa parenterals Fresenius Kabi(China) CR Double-Crane Kelun Group Shandong Qidu Pharmaceutical Shandong Hualu Pharmaceutical Minsheng Pharma Kanglepharm